ADAM-17 Activity and Its Relation to ACE2: Implications for Severe COVID-19
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25115911 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Jiangming Sun und 5 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular Research-Translational Studies, Department of Clinical Sciences Malmö, Lund University, 205 02 Malmö, Sweden. Hauptthemen laut MEDLINE: COVID-19, ADAM17 Protein, Angiotensin-Converting Enzyme 2, SARS-CoV-2. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Kockska foundation, Swedish research foundation, Swedish heart and lung foundation.
Abstract (Originalsprache)
There is a lack of studies aiming to assess cellular a disintegrin and metalloproteinase-17 (ADAM-17) activity in COVID-19 patients and the eventual associations with the shedding of membrane-bound angiotensin-converting enzyme 2 (mACE2). In addition, studies that investigate the relationship between ACE2 and ADAM-17 gene expressions in organs infected by SARS-CoV-2 are lacking. We used data from the Massachusetts general hospital COVID-19 study (306 COVID-19 patients and 78 symptomatic controls) to investigate the association between plasma levels of 33 different ADAM-17 substrates and COVID-19 severity and mortality. As a surrogate of cellular ADAM-17 activity, an ADAM-17 substrate score was calculated. The associations between soluble ACE2 (sACE2) and the ADAM-17 substrate score, renin, key inflammatory markers, and lung injury markers were investigated. Furthermore, we used data from the Genotype-Tissue Expression (GTEx) database to evaluate ADAM-17 and ACE2 gene expressions by age and sex in ages between 20–80 years. We found that increased ADAM-17 activity, as estimated by the ADAM-17 substrates score, was associated with COVID-19 severity (p = 0.001). ADAM-17 activity was also associated with increased mortality but did not reach statistical significance (p = 0.06). Soluble ACE2 showed the strongest positive correlation with the ADAM-17 substrate score, follow by renin, interleukin-6, and lung injury biomarkers. The ratio of ADAM-17 to ACE2 gene expression was highest in the lung. This study indicates that increased ADAM-17 activity is associated with severe COVID-19. Our findings also indicate that there may a bidirectional relationship between membrane-bound ACE2 shedding via increased ADAM-17 activity, dysregulated renin–angiotensin system (RAS) and immune signaling. Additionally, differences in ACE2 and ADAM-17 gene expressions between different tissues may be of importance in explaining why the lung is the organ most severely affected by COVID-19, but this requires further evaluation in prospective studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cardiovascular Research-Translational Studies, Department of Clinical Sciences Malmö, Lund University, 205 02 Malmö, Sweden.
- Department of Cardiology, Skåne University Hospital, 205 02 Malmö, Sweden.
- Wallenberg Center for Molecular Medicine, Lund University, 221 00 Lund, Sweden.
- Department of Laboratory Medicine, Lund University, 221 00 Lund, Sweden.
- Department of Emergency and Internal Medicine, Skånes University Hospital, 214 28 Malmö, Sweden.
- Department of Clinical Sciences Malmö, Lund University, 214 28 Malmö, Sweden.
ORCID-Profile: Jiangming Sun, Per Swärd
Förderung
- Kockska foundation
- Swedish research foundation
- Swedish heart and lung foundation
- Swedish society for Medical Research
- Swedish society of Medicine
- Emil and Wera Cornell foundation
- ALF grants Region Skåne
- Crawfoord foundation
Zitieren
APA
Sun, J., Edsfeldt, A., Svensson, J., Ruge, T., Goncalves, I., & Swärd, P. (2024). ADAM-17 Activity and Its Relation to ACE2: Implications for Severe COVID-19. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25115911
Vancouver
Sun J, Edsfeldt A, Svensson J, Ruge T, Goncalves I, Swärd P. ADAM-17 Activity and Its Relation to ACE2: Implications for Severe COVID-19. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25115911
BibTeX
@article{Sun2024,
author = {Sun, Jiangming and Edsfeldt, Andreas and Svensson, Joel and Ruge, Toralph and Goncalves, Isabel and Swärd, Per},
title = {ADAM-17 Activity and Its Relation to ACE2: Implications for Severe COVID-19},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25115911}
}
EUVIMED